PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 27 filers reported holding PHARMACYTE BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,158 | -26.6% | 219,110 | +0.0% | 0.00% | – |
| Q2 2023 | $626,551 | +22.8% | 219,074 | +25.0% | 0.00% | – |
| Q1 2023 | $510,018 | +99707.8% | 175,264 | 0.0% | 0.00% | – |
| Q4 2022 | $511 | -99.9% | 175,264 | -0.2% | 0.00% | – |
| Q3 2022 | $421,000 | +6.3% | 175,607 | 0.0% | 0.00% | – |
| Q2 2022 | $396,000 | +0.5% | 175,607 | +2.4% | 0.00% | – |
| Q1 2022 | $394,000 | +89.4% | 171,523 | +105.2% | 0.00% | – |
| Q4 2021 | $208,000 | +41.5% | 83,575 | +79.3% | 0.00% | – |
| Q3 2021 | $147,000 | – | 46,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
| SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
| K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
| EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
| CSS LLC/IL | 13,186 | $27,691 | 0.00% |
| Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |